QuickView for Heterogeneous nuclear ribonucleoprotein M, PY nuclear localisation signal (biogroup)

1. L1000 CMAP - Colorectal cancer HT29 cells treated with ligand perturbagens
2. L1000 CMAP - Colorectal cancer DLD-1 cells with shRNA-mediated gene knockdown
3. L1000 CMAP - Carcinoma of prostate PC3 cells treated with ligand perturbagens
4. L1000 CMAP Prostate cancer PC3 cells with gene overexpression perturbations (2 of 2)
5. L1000 CMAP Prostate cancer PC3 cells with gene overexpression perturbations (1 of 2)

There were no matches for Heterogeneous nuclear ribonucleoprotein M, PY nuclear localisation signal

There were no clinical trials for Heterogeneous nuclear ribonucleoprotein M, PY nuclear localisation signal